Gabay C, Roux-Lombard P, de Moerloose P, Dayer J M, Vischer T, Guerne P A
Division de Rhumatologie, Hôpital Cantonal Universitaire, Geneva, Switzerland.
J Rheumatol. 1993 May;20(5):815-21.
To investigate if the low C-reactive protein (CRP) response frequently observed in systemic lupus erythematosus (SLE) is related to an impaired expression of interleukin 6 (IL-6), considered its main inducer, we studied serum IL-6 and CRP levels in 37 patients with SLE and 22 with rheumatoid arthritis (RA). Results show that in contrast to CRP, IL-6 levels are significantly higher in SLE than in RA. A linear regression analysis shows a positive correlation between levels of these 2 molecules in RA but not in SLE. Similarly, levels of fibrinogen, another acute phase protein mainly induced by IL-6, did not correlate with IL-6 in SLE. Our results suggest an impairment of part of the acute phase response to IL-6 that might play a role in the pathogenesis of SLE.
为研究系统性红斑狼疮(SLE)中常见的低C反应蛋白(CRP)反应是否与白细胞介素6(IL-6)表达受损有关(IL-6被认为是CRP的主要诱导因子),我们研究了37例SLE患者和22例类风湿关节炎(RA)患者的血清IL-6和CRP水平。结果显示,与CRP相反,SLE患者的IL-6水平显著高于RA患者。线性回归分析表明,这两种分子的水平在RA患者中呈正相关,而在SLE患者中则无相关性。同样,另一种主要由IL-6诱导的急性期蛋白纤维蛋白原的水平在SLE患者中也与IL-6不相关。我们的结果提示,对IL-6的部分急性期反应受损可能在SLE的发病机制中起作用。